Find Icodextrin manufacturers, exporters & distributors on PharmaCompass

DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

Virtual Booth

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

4 API Suppliers, 1 USDMF, 1 KDMF, 1 NDC API, 3 Listed Suppliers

4 API Suppliers
1 USDMF
1 KDMF
1 NDC API
3 Listed Suppliers

DEVELOPMENTS

2 Drugs in Development

2 Drugs in Development

FINISHED DOSAGE FORMULATIONS

7 FDF Dossiers, 1 FDA Orange Book, 2 Europe, 1 Canada, 3 South Africa

7 FDF Dossiers
1 FDA Orange Book
2 Europe
1 Canada
3 South Africa

RELATED EXCIPIENT COMPANIES

1 Actylis

relatedExcipients
1 Actylis

DIGITAL CONTENT

1 DATA COMPILATION #PharmaFlow, 2 NEWS #PharmaBuzz

media
1 DATA COMPILATION #PharmaFlow
2 NEWS #PharmaBuzz

MARKET PLACE

6 APIs

marketPlace
6 APIs

PATENTS & EXCLUSIVITIES

1 Health Canada Patents

patents
1 Health Canada Patents

Synopsis

ACTIVE PHARMA INGREDIENTS

API Suppliers

USDMF

CEP/COS

JDMF

EU WC

KDMF

NDC API

VMF

Listed Suppliers

API REF. PRICE (USD/KG)

$ 0

MARKET PLACE

API

FDF

0INTERMEDIATES

FINISHED DOSAGE FORMULATIONS

FDF Dossiers

FDA Orange Book

Europe

Canada

Australia

South Africa

Listed Dossiers

DRUG PRODUCT COMPOSITIONS

REF. STANDARDS OR IMPURITIES

EDQM

USP

Others

PATENTS & EXCLUSIVITIES

US Patents

US Exclusivities

Health Canada Patents

DIGITAL CONTENT

Data Compilation #PharmaFlow

Stock Recap #PipelineProspector

Weekly News Recap #Phispers

News #PharmaBuzz

GLOBAL SALES INFORMATION

US Medicaid (USD)

Annual Reports (USD Million)

Finished Drug Prices

1EXCIPIENTS BY APPLICATIONS

Chemistry

Click the arrow to open the dropdown

Click the button for full data set

Also known as: Guanabenz, 5051-62-7, Hydrazinecarboximidamide, 2-[(2,6-dichlorophenyl)methylene]-, (e)-, Dsstox_cid_25666, Dsstox_rid_81042, Dsstox_gsid_45666

Molecular Formula

C₈H₈Cl₂N₄

Molecular Weight

231.08 g/mol

InChI Key

WDZVGELJXXEGPV-UHFFFAOYSA-N

An alpha-2 selective adrenergic agonist used as an antihypertensive agent.

1 2D Structure

Icodextrin

2 Identification

2.1 Computed Descriptors

2.1.1 IUPAC Name

2-[(2,6-dichlorophenyl)methylideneamino]guanidine

2.1.2 InChI

InChI=1S/C8H8Cl2N4/c9-6-2-1-3-7(10)5(6)4-13-14-8(11)12/h1-4H,(H4,11,12,14)

2.1.3 InChI Key

WDZVGELJXXEGPV-UHFFFAOYSA-N

2.1.4 Canonical SMILES

C1=CC(=C(C(=C1)Cl)C=NN=C(N)N)Cl

2.2 Synonyms

2.2.1 MeSH Synonyms

1. 2,6 Dichlorobenzylideneaminoguanidine

2. 2,6-dichlorobenzylideneaminoguanidine

3. Acetate Wyeth-ayerst, Guanabenz

4. Acetate, Guanabenz

5. Br 750

6. Br-750

7. Br750

8. Guanabenz

9. Guanabenz Acetate

10. Guanabenz Acetate Wyeth-ayerst

11. Guanabenz Monoacetate

12. Monoacetate, Guanabenz

13. Wy 8678

14. Wy-8678

15. Wy8678

16. Wyeth Ayerst Of Guanabenz Acetate

17. Wyeth-ayerst Of Guanabenz Acetate

18. Wytensin

2.2.2 Depositor-Supplied Synonyms

1. Guanabenz

2. 5051-62-7

3. Hydrazinecarboximidamide, 2-[(2,6-dichlorophenyl)methylene]-, (e)-

4. Dsstox_cid_25666

5. Dsstox_rid_81042

6. Dsstox_gsid_45666

7. Cas-5051-62-7

8. Ncgc00024846-03

9. Spectrum_000843

10. Prestwick0_000096

11. Prestwick1_000096

12. Spectrum2_001114

13. Spectrum3_000445

14. Spectrum4_000567

15. Kbiogr_000974

16. Kbioss_001323

17. Divk1c_000010

18. Spbio_001248

19. Spbio_001991

20. Chembl1313657

21. Dtxsid6045666

22. Kbio1_000010

23. Kbio2_001323

24. Kbio2_003891

25. Kbio2_006459

26. Kbio3_001310

27. Ninds_000010

28. Hms2233d12

29. Hms3370a17

30. Bcp30851

31. Tox21_110932

32. Akos017264577

33. Tox21_110932_1

34. Zinc242701441

35. Db00629

36. 2,6-dichlorobenzaldehyde Guanylhydrazone

37. Mrf-0000008

38. Ncgc00024846-08

39. Db-051784

40. Ft-0635524

41. Guanabenzum;wy-8678; Wy 8678; Wy8678

42. N-(2,6-dichlorobenzylidene)-n'-amidino Hydrazine

43. Sr-01000721838

44. Sr-01000721838-5

45. Q27164730

2.3 Create Date

2005-03-25

3 Chemical and Physical Properties

Molecular Formula	C₈H₈Cl₂N₄
Molecular Weight	231.08 g/mol
XLogP3	1.7
Hydrogen Bond Donor Count	2
Hydrogen Bond Acceptor Count	2
Rotatable Bond Count	2
Exact Mass	230.0126017 g/mol
Monoisotopic Mass	230.0126017 g/mol
Topological Polar Surface Area	76.8 Å²
Heavy Atom Count	14
Formal Charge	0
Complexity	228
Isotope Atom Count	0
Defined Atom Stereocenter Count	0
Undefined Atom Stereocenter Count	0
Defined Bond Stereocenter Count	0
Undefined Bond Stereocenter Count	1
Covalently Bonded Unit Count	1

4 Drug and Medication Information

4.1 Drug Indication

For management of High blood pressure

FDA Label

5 Pharmacology and Biochemistry

5.1 Pharmacology

Guanabenz, a centrally acting α-2 adrenergic agonist, is indicated for treatment of hypertension.

5.2 MeSH Pharmacological Classification

Adrenergic alpha-2 Receptor Agonists

Compounds that bind to and activate ADRENERGIC ALPHA-2 RECEPTORS. (See all compounds classified as Adrenergic alpha-2 Receptor Agonists.)

Antihypertensive Agents

Drugs used in the treatment of acute or chronic vascular HYPERTENSION regardless of pharmacological mechanism. Among the antihypertensive agents are DIURETICS; (especially DIURETICS, THIAZIDE); ADRENERGIC BETA-ANTAGONISTS; ADRENERGIC ALPHA-ANTAGONISTS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CALCIUM CHANNEL BLOCKERS; GANGLIONIC BLOCKERS; and VASODILATOR AGENTS. (See all compounds classified as Antihypertensive Agents.)

5.3 Absorption, Distribution and Excretion

Absorption

Approximately 75% absorbed from gastrointestinal tract

5.4 Metabolism/Metabolites

Hepatic

5.5 Biological Half-Life

6 hours.

5.6 Mechanism of Action

Guanabenz's antihypertensive effect is thought to be due to central alpha-adrenergic stimulation, which results in a decreased sympathetic outflow to the heart, kidneys, and peripheral vasculature in addition to a decreased systolic and diastolic blood pressure and a slight slowing of pulse rate. Chronic administration of guanabenz also causes a decrease in peripheral vascular resistance.

API SUPPLIERS